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Abstract
Objective Intrathoracic goiters are a heterogeneous group characterized by limited or extensive substernal extension. Whereas 
the former can be treated through cervicotomy, the latter sometimes requires a cervicosternotomy. Whether cervicosternotomy 
leads to more morbidity remains unclear.
This study aimed to compare intra- and postoperative morbidity in patients treated by cervicotomy or cervicosternotomy for 
intrathoracic goiters and standard thyroidectomy.
Methods In a prospectively gathered cohort undergoing thyroid surgery (2010–2019) intra- and postoperative morbidity of 
cervicotomy (N = 80) and cervicosternotomy (N = 15) for intrathoracic goiters was compared to each other and to a ‘standard’ 
thyroidectomy (N = 1500).
Results An intrathoracic extension prior to surgery was found in 95 (6%) of all thyroidectomies. Eighty patients (84%) were 
operated by cervicotomy and 15 (16%) by cervicosternotomy. The risk of temporary recurrent laryngeal nerve palsy was 
much higher in the cervicosternotomy group (21%) compared to cervicotomy (4%) and standard thyroidectomy (3%). The 
risk of temporary hypocalcemia after cervicotomy (28%) was comparable to a standard thyroidectomy (32%) but higher after 
cervicosternotomy (20%). No cases of permanent hypocalcemia or laryngeal nerve palsy were observed in both groups with 
substernal extension. The need for surgical reintervention was significantly higher in the cervicotomy group (6%) compared 
to cervicosternotomy (0%) and standard thyroidectomy (3%).
Conclusion In patients undergoing thyroid surgery for an intrathoracic goiter, cervicosternotomy was associated with more 
temporary laryngeal nerve palsy, but none of the interventions resulted in higher risks of permanent nerve damage, perma-
nent hypocalcemia, or reintervention for bleeding. Reintervention was even more common after cervicotomy compared to 
cervicosternotomy.
Level of evidence IV
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Introduction
Although there is no uniform definition of an intrathoracic 
goiter, many agree that a thyroid gland volume over 50% 
below the thoracic inlet is an important criterion [1–4]. 
“Retrosternal” and “substernal” goiters are synonyms. In the 
absence of a clear definition, the exact prevalence is difficult 
to determine. In patients undergoing thyroid surgery, the 
prevalence of intrathoracic goiters is approximately 1–21% 
[1, 2, 5].
In the case of an asymptomatic cervical goiter, con-
servative treatment may be followed [6]. In case of an 
asymptomatic, intrathoracic goiter two valid options are 
available: surgery or observation with monitoring. These 
options depend on the size of the substernal goiter and 
the patient characteristics (fit for surgery or not). Possi-
ble risks of a conservative policy consist of acute airway 
obstruction, bleeding, vena cava compression, malignancy 
and major surgery [7]. Suppressive hormonal therapy can 
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reduce goiters in size, but in most cases, this will not be 
sufficient to alleviate compressive symptoms [6, 8].
The only successful surgical treatment for intrathoracic 
goiter is a total thyroidectomy with “en bloc” removal of 
the intrathoracic part, without capsular disruption [1, 6]. 
For this procedure, two different approaches are available: 
the cervical one through cervicotomy and the thoracic 
one through cervicosternotomy. In most cases, a cervi-
cal approach is sufficient to extract the mediastinal thy-
roid part by digital manoeuvres [1–6]. In more extensive 
cases a thoracic access is needed, in particular for goiters 
descending into the posterior mediastinum and below the 
aortic arch [1–3, 5] or with a diameter larger than the tho-
racic inlet [1, 5]. Less frequent are primary intrathoracic 
goiters, patients with severe kyphosis, superior vena cava 
syndrome, distortion of mediastinal structures and goiters 
with malignancy characteristics such as strong adhesions 
with neovascular capsule and microcalcifications [1, 4, 5].
This study aimed to assess intra- and postoperative 
morbidity in patients treated for intrathoracic goiter by 
cervicotomy or cervicosternotomy in comparison to a total 
surgical cohort of 1500 patients.
Methods
Study design
All consecutive adult patients undergoing thyroid surgery 
at the Onze Lieve Vrouw (OLV) hospital in Aalst, Belgium 
were enrolled in a prospective cohort to evaluate morbid-
ity and outcome in a tertiary referral center. Recruitment 
of patients was started in January 2010 and is still ongo-
ing. All data have been collected in a prospective man-
ner, and all consecutive patients during the study were 
invited to participate (none declined consent). The cohort 
is registered at Research Registry (researchregistry6182) 
in accordance with the World Medical Association’s Dec-
laration of Helsinki 2013.
Setting
All procedures were performed by a single, extensively 
trained endocrine surgeon (SVS), with a personal experi-
ence of over 5000 cases and an annual caseload of over 
250 cases a year. The OLV Hospital in Aalst is the ninth 
largest general hospital in Belgium, with 844 recognized 
beds. It is a tertiary referral center for endocrine surgery. 
In 2018, almost 57,000 surgical interventions were per-
formed and over 1 out of 30 thyroidectomies in Belgium 
is performed at this hospital.
Ethics
Prospective data collection in these patients has been 
approved by the Ethics Committee of the OLV Hospital in 
Aalst, and all patients provided written informed consent.
Study participants
The database was locked and ready for analysis on Novem-
ber 11th, 2019. In the overall cohort, all patients receiving 
surgery for intrathoracic goiter were selected and compared 
to the first 1500 consecutive patients operated for other thy-
roid conditions (referred to as ‘standard thyroidectomy’). 
The study cohort is outlined in supplementary Fig. 1. In the 
presence of a retrosternal goiter (on ultrasound or on clini-
cal examination) a CT-scan was performed. The indication 
for surgery and choice of surgical technique was discussed 
at a multidisciplinary meeting, consisting of at least one 
radiologist, nuclear medicine specialist, endocrinologist, 
endocrine surgeon and pathologist. In case of a suspicious 
nodule on US, a fine needle aspiration was always recom-
mended and performed to exclude a possible malignancy, 
regardless of the size of the thyroid or the possible retros-
ternal extent. More extended multidisciplinary planning was 
done for patients undergoing a possible cervicosternotomy, 
including a pulmonary check-up by an anesthesiologist and 
pneumologist, with lung function testing and bronchoscopy. 
The choice of the endotracheal tube size for anaesthesia was 
based on findings of the bronchoscopy and measurements 
of tracheal diameter on imaging. Pre-operative respiratory 
physiotherapy was foreseen to reduce the risk of pulmonary 
complications.
Surgical characteristics
As proposed by the IONM study group guidelines, preopera-
tive laryngoscopy was performed before surgery and IONM 
was used in every single case as part of our routine protocol.
Cervicosternotomy was used for goiters if 50% of the 
volume was located below the plane of the thoracic inlet 
and/or if an additional risk factor was present: wider than the 
thoracic inlet, diving below the aortic arch or in the posterior 
mediastinum. A cervicotomy was used for goiters without 
any of the above findings.
Surgery for an intrathoracic goiter always starts with a 
Kocher incision, exactly the same as the classic cervical 
approach. After identifying the recurrent laryngeal nerve, 
it is monitored and followed further down using the ‘tobog-
gan technique’ as described by Charles Proye [10]. Intra-
operative neuromonitoring during thyroid surgery is used 
in all cases to improve vigilance [11, 12]. It consists of an 
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S-shaped probe for continuous vagal stimulation, a hand-
held bipolar stimulator and acquisition electrodes as previ-
ously described [13, 14].
Based on the preoperative multidisciplinary discussion 
and the perioperative findings, a sternal split is performed 
when the intrathoracic part cannot be safely delivered.
Definitions
In our series, the following definition of a substernal goiter 
was used consistently: more than 50% of the thyroid is 
located below the thoracic inlet. Patients selected for sur-
gery for an intrathoracic goiter all received a pre-operative 
neck ultrasound, and an additional computed tomography 
(CT) scan or PET-CT scan to determine the optimal surgical 
technique [3, 9]. In case of a suspicious nodule on US, a fine 
needle aspiration was always recommended and performed, 
regardless the size of the thyroid or the possible retrosternal 
extent to exclude an underlying malignancy.
Permanent hypocalcemia was defined as hypocalcemia 
lasting at least 6 months after surgery (albumin-corrected 
calcium level < 2.00 mmol/l or the need for calcium and/or 
activated vitamin D substitution to maintain normal calcium 
levels).
Pre-operative laryngoscopy is performed before anes-
thetic induction of the patient. Post-operative laryngoscopy 
is performed within 24hrs after surgery. In case of a docu-
mented RLN palsy, the patient is routinely followed by the 
ENT and the surgical department until recovery or persis-
tence. Temporary RLN palsy was defined as a recuperation 
of vocal cord mobility on laryngoscopy within one year after 
surgery. Permanent palsy was defined as absence of vocal 
cord mobility on laryngoscopy after a one-year follow-up.
Outcome
For all patients, data were collected on age (categorized 
as < 40, 40–59 and ≥ 60 years), sex (men or women), body 
mass index (categorized as < 25, 25–29, and ≥ 30 kg/m2), 
period of surgery (categorized as 2010–2012, 2013–2015, 
2016–2019) and health status as defined by the American 
Society of Anaesthesiologist association [ASA, categorized 
as I–II [healthy or mild], and III–IV (severe systemic dis-
ease)]. Surgical indications were categorized as multinodular 
Fig. 1  Preoperative Computed 
Tomography: intrathoracic 
goiter (a) in anterior mediasti-
num, (b) in posterior medi-
astinum, (c) extending below 
the carina (d) causing trachea 
deviation and narrowing
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goiter, Graves’ disease, solitary nodule, toxic adenoma, ami-
odarone-induced hyperthyreosis and cancer.
Primary outcome variables were: (1) hypocalcemia (tran-
sient and permanent), (2) recurrent laryngeal nerve (RLN) 
palsy (transient and permanent), (3) reintervention for bleed-
ing, (4) Clavien score ≥ 3 (indicating surgical reinterven-
tion). Hypocalcemia was only assessed in individuals receiv-
ing a total or completion thyroidectomy and was defined as 
a parathyroid hormone (PTH) level of < 15 ng/l 4 h after 
surgery. RLN palsy was only assessed in individuals with 
normal results at the pre-operative vocal cord assessment 
(defined as a moving vocal cord on laryngoscopy, performed 
by an independent ENT specialist).
Statistical analysis
Descriptive statistics were compared by means of the Chi-
square test, with p values < 0.05 indicating statistically sig-
nificant results.
All primary outcomes were assessed by means of logistic 
regression, presented as odds ratios (OR) and 95% confi-
dence intervals and adjusted for age, sex, BMI, period of 
surgery, health status, indication for surgery and hemi- or 
total thyroidectomy. Data on other complications was also 
collected and described.
Indicators for surgical complexity were weight of the 
resected specimen (grams), blood loss (mL), duration of 
surgery (minutes) and length of hospital stay (days). all 
were presented as median with interquartile ranges (IQR). 
The indicators were compared between cervicosternotomy 
and cervicotomy, and standard thyroidectomy by means of 
the Mann–Whitney U test, with p values < 0.05 indicating 
statistically significant differences.




In this cohort, 1595 patients underwent thyroid surgery. 
No intrathoracic extension was seen in 1500. These were 
all treated through cervicotomy. In 95 patients (6%) an 
intrathoracic goiter was present. Eighty patients had a 
limited intrathoracic goiter and were operated by cervi-
cotomy. In 15 patients an extensive intrathoracic goiter 
was present, requiring a resection by cervicosternotomy. 
Clinical characteristics of the different cohorts are shown 
in Table 1. Patients undergoing cervicotomy and cervi-
costernotomy were significantly older than the reference 
standard thyroidectomy group. A higher proportion of 
patients were men. BMI and ASA grade were slightly 
higher among the cervicosternotomy and cervicotomy 
groups.
Clinical presentation of the 15 patients with extensive 
intrathoracic goiter is described below. Ten patients (67%) 
had compressive symptoms (superior vena cava syndrome, 
hoarseness or stridor). Four patients had an asymptomatic, 
but clinically visible goiter. One patient was diagnosed 
incidentally on a routine chest X-ray. The 15 extensive 
retrosternal goiters were located in the anterior (N = 4, 
Fig.  1a) and posterior mediastinum (N = 11, Fig.  1b). 
Twelve goiters reached below the aortic arch (Fig. 1c, 
Fig. 2). The first rib, the upper edge of the manubrium 
and the posterior edge of the first thoracic vertebrae were 
the landmarks to determine the thoracic inlet on CT-scan. 
Eight goiters had a larger diameter in the axial plane than 
the diameter of thoracic inlet, 13 goiters crossed the mid-
line. One of the 15 goiters showed malignancy character-
istics. There were no primary intrathoracic goiters. All 95 
patients with a suspected retrosternal thyroid on US or on 
clinical examination underwent a CT scan. In the control 
group, an additional 365 patients underwent a CT scan 
for other reasons. Sixty-Eight percent of all 1595 patients 
underwent a scintigraphy. Only 69 patients in the whole 
cohort underwent a PET/CT.
Primary outcomes
No cases of permanent hypocalcemia were recorded after 
total thyroidectomy by cervicosternotomy. However, 20%, 
28% and 32% of cervicosternotomy, cervicotomy and 
standard thyroidectomy cases developed a transient hypoc-
alcemia (Table 2a), however not resulting in statistically 
different risks after adjustment for confounding variables 
(Table 3).
No cases of permanent RLN palsy were observed for all 
retrosternal goiters. Three cases of transient nerve palsy 
were observed in the cervicotomy and cervicosternotomy 
groups (Table 2a), resulting in an increased risk of RLN 
paralysis for cervicosternotomy compared to standard thy-
roidectomy after adjustment for confounding variables 
[OR = 4.20 (1.03–17.07)] (Table 3).
There were no surgical reinterventions for bleeding in the 
cervicosternotomy group, and only 5 (6%) and 39 (3%) in the 
cervicotomy and standard thyroidectomy groups (Table 2a). 
Differences were not statistically significant (Table 3).
Three patients of the cervicosternotomy group had pul-
monary morbidity, including a post-sternotomy syndrome 
with persistent pleural effusion, a postoperative pneumo-
nia and a right apical pneumothorax. None of the patients 
receiving cervicotomy or standard thyroidectomy had pul-
monary complications (Fig. 2). 
Updates in Surgery 
1 3
Surgical complexity indicators
For hemithyroidectomies in the cervicotomy group, the 
duration of surgery was slightly longer compared to standard 
hemithyroidectomy (median 53 min compared to 40 min). 
For total thyroidectomies, the weight of the resected speci-
men (median 123 g versus 64 g), the amount of blood loss 
(37 mL versus 18 mL) and duration of surgery (73 min ver-
sus 65 min) were higher compared to the standard thyroid-
ectomy group. In the cervicosternotomy group, the weight 
of the resected specimen and blood loss were higher, and the 
duration of surgery and length of stay longer compared to 
standard thyroidectomy, for both hemi-thyroidectomy and 
total thyroidectomy (Table 2b).
Discussion
This surgical cohort of 1500 consecutive thyroid surgery 
procedures contains one of the largest series of retrosternal 
goiters ever reported. All procedures were carried out using 
a standardized approach and standardized definitions and 
Table 1  Descriptive characteristics of all individuals operated by cervicosternotomy or cervicotomy for an intrathoracic goiter, compared to 
standard thyroidectomy
p-values < 0.05 are considered statistically significant
ASA American Society for Anaesthesiology
Standard thyroidectomy 
(reference, N = 1500)
Cervicotomy (N = 80) Cervicosternotomy (N = 15)
N (%) N (%) p value
(Chi-square)
N (%) p value
(Chi-square)
Age (years)
  < 40 289 (19.3) 2 (2.5)  < 0.001 0 (0.0)  < 0.001
 40–59 714 (47.6) 30 (37.5) 0 (0.0)
  ≥ 60 497 (33.1) 48 (60.0) 15 (100)
Sex
 Male 304 (20.3) 30 (37.5)  < 0.001 10 (66.7)  < 0.001
 Female 1196 (79.7) 50 (62.5) 5 (33.3)
Body mass index (kg/m2)
  < 25 690 (46.0) 24 (30.0) 0.004 4 (26.7) 0.263
 25–29.9 522 (34.8) 30 (37.5) 8 (53.3)
  ≥ 30 288 (19.2) 26 (32.5) 3 (20.0)
ASA-score
 I (healthy) or II (mild) 1333 (88.9) 61 (74.2) 0.001 7 (46.7)  < 0.001
 III–IV (severe or life threatening) 167 (11.1) 19 (23.8) 8 (53.3)
Pre-op vocal cord assessment
 Abnormal 19 (1.3) 1 (1.3) 0.990 1 (6.7) 0.068
Thyroidectomy
 Partial 457 (30.5) 12 (15.0) 0.003 5 (33.3) 0.810
 Total 1043 (69.5) 68 (85.0) 10 (66.7)
Indication
 Benign 1,408 (93.9) 78 (97.5) 0.181 14 (93.3) 0.932
 Malign 92 (6.1) 2 (2.5) 1 (6.7)
Indication benign
 Multinodular goiter 785 (52.3) 67 (83.8)  < 0.001 14 (93.3) 0.052
 Graves 158 (10.5) 2 (2.5) 0 (0.0)
 Solitary nodule 375 (25.0) 6 (7.5) 0 (0.0)
 Toxic adenoma 64 (4.3) 2 (2.5) 0 (0.0)
 Amiodarone 26 (1.7) 1 (1.3) 0 (0.0)
Year of surgery
 2010–2012 515 (34.3) 3 (3.8)  < 0.001 1 (6.7) 0.006
 2013–2015 466 (31.1) 3 (3.8) 3 (20.0)
 2016–2019 519 (34.6) 74 (92.5) 11 (73.3)
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recorded without missing data. This single centre, prospec-
tive surgical cohort showed a prevalence of 6% of intratho-
racic goiter, comparable to other published data [2, 5, 15].
In 84% of all intrathoracic goiters, surgery through 
cervicotomy was feasible to remove all thyroid tissue. 
Our number of people treated by cervicosternotomy 
seems quite high. This could be related to consistently 
Table 2  (a) Post-operative morbidity and (b) indicators of surgical complexity in all individuals operated by cervicosternotomy or cervicotomy 
for retrosternal goiters, compared to standard thyroidectomy
p-values < 0.05 are considered statistically significant
(a)
Primary results Standard thyroidectomy 
(reference)
(N = 1500)
Cervicotomy (N = 80) Cervicosternotomy (N = 15)
N (%) N (%) p value (Chi-
square)
N (%) p value (Chi-
square)
Hypocalcemia (only in total thyroidectomy)
 All 365 (35.0) 19 (27.9) 0.236 2 (20.0) 0.322
 Transient 333 (31.9) 19 (27.9) 0.395 2 (20.0) 0.386
 Permanent 32 (3.1) 0 (0.0) 0.129 0 (0.0) 0.539
Recurrent laryngeal nerve palsy (only with normal preoperative vocal cords)
 All 65 (4.4) 3 (3.8) 0.802 3 (21.4) 0.002
 Transient 41 (2.8) 3 (3.8) 0.610 3 (21.4)  < 0.001
 Permanent 24 (1.6) 0 (0.0) 0.257 (0.0) 0.666
Surgical reintervention for bleed-
ing
39 (2.6) 5 (6.3) 0.053 0 (0.0) 0.527
Clavien score ≥ 3 (requiring surgi-
cal intervention)
39 (2.6) 2 (2.5) 0.956 0 (0.0) 0.527
(b)
Indicators for surgical complexity Standard thyroidectomy 
(reference)
(N = 1500)
Cervicotomy (N = 80) Cervicosternotomy (N = 15)












 Weight of resected specimen 
(grams)
26 (16–44) g 33 (20–70) g 0.225 355 (280–378) g 0.003
[298 g] [152 g] [378 g]
 Length of stay (days) 1 (1–1) days 1 (1–1) days 0.320 7 (4–8) days  < 0.001
[15 days] [1 day] [8 days]
 Blood loss (mL) 6 (2–13) mL 10 (4–32) mL 0.126 374 (263–695) mL  < 0.001
[498 mL] [600 mL] [1000 mL]
 Duration of surgery (minutes) 40 (35–50) min 53 (40–70) min 0.041 140 (135–140) min  < 0.001
[275 min] [90 min] [300 min]
Total thyroidectomy
 Weight of resected specimen 
(grams)
64 (36–112) g 123 (69–172) g  < 0.001 430 (400–502) g  < 0.001
[848 g] [528 g] [776 g]
 Length of stay (days) 1 (1–1) days 1 (1–1) days 0.763 5 (1–7) days  < 0.001
[13 days] [21 days] [10 days]
 Blood loss (mL) 18 (9–38) mL 37 (14–71) mL  < 0.001 350 (204–634) mL  < 0.001
[1290 mL] [536 mL] [1100 mL]
 Duration of surgery (minutes) 65 (55–85) min 73 (60–90) min 0.029 180 (150–200) min  < 0.001
[540 min] [180 min] [240 min]
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following the flowchart (Fig. 3) and the fact of being a 
tertiary referral centre. Immediate morbidity was com-
parable to a standard thyroidectomy, only transient RLN 
palsy occurred more after cervicosternotomy. There was 
no increased risk of permanent hypocalcemia, permanent 
RLN palsy or reinterventions for bleeding, despite the 
increased complexity of surgery as shown by increased 
duration of surgery, blood loss and weight of the speci-
men. No patients in the sternotomy group developed a 
keloid scar or excessive scar formation. Remarkably, the 
incidence of transient hypocalcemia was higher in the 
standard thyroidectomy group, when comparing to sur-
gery for intrathoracic goiters. This standard thyroidectomy 
group mainly includes surgery for Graves’ disease and 
thyroid cancer with central neck dissection, both known 
risk factors for hypoparathyroidism. The absent perma-
nent hypocalcemia in all patients with intrathoracic goiter 
could be due to the low number of cases, the extensive 
experience of the surgeon or a surgical bias. In cases with 
retrosternal goiter, it is of utmost importance to not harm 
the upper 2 parathyroid glands, because of the high risk 
of not viewing or damaging the blood supply of the lower 
parathyroid glands.
The major strengths of this study are the standard-
ized pre-operative preparation, surgical procedure and 
post-operative follow-up, and the large series of patients 
operated by a highly experienced endocrine surgeon. In 
addition, detailed information has been collected on demo-
graphics and disease-related characteristics, that could 
confound the risk of the major complications.
The authors acknowledge there may be residual con-
founding variables and only a small set of confounders 
was used because of limited power. However, despite a 
different baseline situation and an a-priori higher risk of 
poorer outcome, the differences between the groups were 
still relatively limited for most outcomes.
Table 3  The risk of hypocalcemia and recurrent laryngeal nerve palsy among individuals operated with cervicotomy or cervicosternotomy com-
pared to standard thyroidectomy, by means of (multivariable) logistic regression
CI confidence interval
a Adjusted for age, sex, body mass index, ASA score, hemi- or total thyroidectomy, period of surgery
b Only individuals receiving total thyroidectomy are included





odds ratio (95% CI)
Cervicosternotomy 
(N = 15),
odds ratio (95% CI)
Crude Adjusteda Crude Adjusteda




























Fig. 2  Specimen of an intrathoracic goiter, weighting 534 g, resected 
using the thoracic approach in one of the included patients
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According to our experience, surgery for an intratho-
racic goiter is especially challenging if the goiter is shaped 
like an apple and/or crosses the midline of the mediasti-
num. Previous studies also reported an iceberg-shaped 
goiter or a pure intrathoracic goiter as an independent risk 
factor for an extra cervical approach [15, 16].
The preoperative decision to use a thoracic approach 
entails interesting advantages. First of all, the patient can 
be prepared and informed about the procedure and possible 
specific risks. Second, the surgeon can be optimally pre-
pared if the decision about the approach is made in advance. 
Third, the assistance of a thoracic surgeon (if the endocrine 
surgeon lacks skill to perform a sternotomy and thoracic dis-
section) and the specific material can be provided. Fourth, 
the anesthesiologist can make a more accurate preoperative 
evaluation of the patient and his perioperative needs. Moreo-
ver, when a thoracic approach is indicated and a cervical 
approach is applied instead, the risk of complications may 
increase. In specific, the performance of digital manipu-
lations to retract the intrathoracic part of the goiter will 
increase the risk of incomplete removal and morcellation 
of the thyroid resulting in a “forgotten” goiter [1]. This is 
mediastinal thyroid tissue remaining after a so-called “total” 
thyroidectomy. Another risk of morcellation is soiling in the 
case of a malignant goiter. Performing a thoracic approach 
can reduce the risk of a traumatic hemorrhage, because the 
surgeon is not dissecting blindly in the area of the great 
vessels [1, 2, 7, 16]. Additionally, there are arguments for a 
reduced risk of RLN palsy and hypoparathyroidism in a tho-
racic approach compared to digitally cervical retraction [4, 
7]. More blood loss during surgery and an increased hospital 
stay have been reported for cervicosternotomy compared to 
cervical approaches [2]. This was confirmed in the present 
study. This highlights the increased complexity of the surgi-
cal procedure when adding a sternotomy. However, cervicos-
ternotomy does not lead to an excessive risk of major com-
plications including RLN palsy and hypocalcemia, besides 
an increased risk of pulmonary complications [4, 7, 9, 15, 
17]. No reintervention for bleeding was noted in the cervi-
costernotomy group in our series. It is a fact that mediastinal 
vessel exposure, mediastinal vessel ligation and intraopera-
tive bleeding control from the mediastinum are better with 
sternotomy compared to the ‘blind’, manual dissection in 
case of cervicotomy.
Understanding the benefits and disadvantages and deter-
mining the probability of a thoracic approach still remain the 
Fig. 3  Flowchart for the decision-making process
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biggest challenges. Every preoperative planning for thyroid 
surgery, either cervical or thoracic, requires an ultrasound. A 
supplementary scintigraphy can be carried out if the thyroid-
stimulating hormone is low or suppressed. If the ultrasound 
indicates a risk of a retrosternal goiter or when the border of 
the lower pole can’t be felt on clinical examination, a neck 
and chest CT should be done to evaluate its size and location 
in relation to the surrounding structures [1–4].
Because the more invasive nature does not translate into 
more associated morbidity, recent literature suggests that a 
thoracic approach should be considered more often in the 
preoperative phase [2, 18]. Not every goiter reaching below 
the aortic arch needs a thoracic approach. It must be empha-
sized that there is no reason to avoid the use of this type of 
access, keeping in mind the benefits, or the risk of forgotten 
goiters in intrathoracic goiter which would need an invasive 
procedure afterwards anyway [1, 5, 18].
Based on this information and our own experience, we 
created a flow chart, which can guide surgeons in the pre-
operative decision-making process for dealing with multi-
nodular goiters (Fig. 3). The algorithm shows that in the case 
of an asymptomatic cervical goiter, a conservative approach 
is recommended. In case of a substernal goiter, a CT-scan 
should be performed, and surgery discussed with the patient 
to prevent future complications. In most cases, a full ster-
notomy is preferred as it provides excellent visualization of 
the goiter, mediastinum and related structures [4]. In some 
cases, a less invasive approach can be sufficient: sternal 
split, lateral thoracotomy and posterolateral thoracotomy 
are described previously [1, 4, 19].
In conclusion, this study shows that despite its invasive-
ness, surgery for goiters with retrosternal extension is safe 
without an excessive risk of major complications. Reinter-
vention was higher in the cervicotomy group compared to 
the cervicosternotomy group. An extensive standardized 
pre-operative preparation, a CT-scan to determine the extent 
and complexity and multidisciplinary approach are crucial 
in surgical decision making.
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